|
Daxocox
|
45 mg
|
EU/2/21/270/017
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
20-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/017 |
45 mg |
3 |
Blisteris, 4 tablete |
-
|
|
|
LETIFEND
|
-
|
EU/2/16/195/003
|
Laboratorios LETI, S.L. unipersonal, Spānija
|
QI07A
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for solution for injection
|
| International name (active substance): |
Recombinant Protein Q from Leishmania infantum MON-1
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Apr-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/195/003 |
|
5 |
Stikla flakons, 1 deva |
-
|
|
|
Contacera
|
20 mg/ml
|
EU/2/12/144/001
|
Zoetis Belgium S.A., Beļģija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
15-Nov-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/144/001 |
20 mg/ml |
1 |
Flakons, 20 ml |
-
|
|
|
Advocate Spot-on maziem kaķiem un seskiem
|
-
|
EU/2/03/039/013
|
Bayer Animal Health , Vācija
|
QP54AB52
|
ferrets; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
01-Apr-2003
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/013 |
|
4 |
Pipete, 0,4 ml |
-
|
|
|
BioBos Respi 3
|
-
|
V/I/25/0036
|
Bioveta, a.s., Čehija
|
QI02AL04
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
29-May-2025
|
| Marketing authorisation valid until: |
28-May-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 28052025LI (19-May-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0036-01 |
|
1 |
Plastmasas flakons, 5 deva |
[PDF]
[PDF]
|
| V/I/25/0036-02 |
|
1 |
Stikla flakons, 5 deva |
[PDF]
[PDF]
|
| V/I/25/0036-03 |
|
1 |
Plastmasas flakons, 25 deva |
[PDF]
|
| V/I/25/0036-04 |
|
1 |
Stikla flakons, 25 deva |
[PDF]
|
|
|
Loxitab
|
2.5 mg
|
EU/2/23/301/008
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
19-Oct-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/301/008 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|
|
Trilorale
|
50 mg/ml
|
EU/2/24/313/003
|
Axience, Francija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral solution
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/313/003 |
50 mg/ml |
1 |
Polipropilēna pudele, 10 ml |
-
|
|
|
GALLIPRANT
|
60 mg
|
EU/2/17/221/003
|
Elanco GmbH, Vācija
|
QM01AX92
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Grapiprant
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
09-Jan-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/221/003 |
60 mg |
7 |
Polietilēna pudele, 7 tablete |
-
|
|
|
Bovela
|
-
|
EU/2/14/176/008
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI02AD02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health USA Inc., ASV
|
| Date of authorisation/renewal: |
21-Dec-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/176/008 |
|
10 |
Stikla flakons, 10 deva |
-
|
|
|
CircoMax Myco
|
-
|
EU/2/20/264/004
|
Zoetis Belgium S.A., Beļģija
|
QI09AL08
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a ORF2 protein, Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein, Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
09-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/264/004 |
|
10 |
ABPE flakons, 50 ml |
-
|
|
|
FRONTPRO
|
28.3 mg
|
EU/2/19/240/005
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >4–10 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/005 |
28,3 mg |
1 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
Fluralaner Intervet
|
400 mg
|
EU/2/25/346/016
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/346/016 |
|
6 |
Blisteris, 1 tablete |
-
|
|
|
Nobivac DP Plus
|
-
|
EU/2/20/265/002
|
Intervet International BV, Nīderlande
|
QI07AD03
|
puppies
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live Canine distemper virus (CDV) strain Onderstepoort, Live recombinant canine parvovirus strain 630a
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International BV, Nīderlande
|
| Date of authorisation/renewal: |
09-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/265/002 |
|
25 |
Stikla flakons, 1 deva |
-
|
|
|
Posatex
|
-
|
EU/2/08/081/003
|
Intervet International B.V, Nīderlande
|
QS02CA91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
ear drops, suspension
|
| International name (active substance): |
Mometasone fuorate,Posaconazole,Orbifloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
SP Bray, Īrija
|
| Date of authorisation/renewal: |
23-Jun-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/081/003 |
|
1 |
ABPE pudele, 35,1 ml |
-
|
|
|
Bovela
|
-
|
EU/2/14/176/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI02AD02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health USA Inc., ASV
|
| Date of authorisation/renewal: |
21-Dec-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
[PDF] 180917LI (18-Sep-2017)
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/176/001 |
|
1 |
Stikla flakons, 5 deva |
[PDF]
[JPG]
[JPG]
[JPG]
|
|
|
Eluracat
|
20 mg/ml
|
EU/2/23/297/001
|
Elanco GmbH, Vācija
|
QH01AX90
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
Capromorelin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
29-Jun-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/297/001 |
|
1 |
Flakons, 10 ml |
-
|
|
|
Isemid
|
2 mg
|
EU/2/18/232/004
|
Ceva Sante Animale,, Francija
|
QC03CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets for oral use
|
| International name (active substance): |
Torasemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CEVA SANTE ANIMALE, Francija;CEVA SANTÉ ANIMALE , Francija
|
| Date of authorisation/renewal: |
09-Jan-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/232/004 |
2 mg |
90 |
Al/OPA/Al/PVH blisteris, 10 tablete |
-
|
|
|
Lotimax
|
112 mg
|
EU/2/24/311/002
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs 2,5–5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
25-Apr-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/311/002 |
112 mg |
1 |
Alumīnija blisteris, 3 tablete |
-
|
|
|
UpCard
|
18.0 mg
|
EU/2/15/184/007
|
Vetoquinol S.A., Francija
|
QC03CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Torasemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
24-Jun-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/184/007 |
18 mg |
3 |
PVH/PHTFE alumīnija blisteris, 10 tablete |
-
|
|
|
Nobilis IB 4 - 91
|
-
|
EU/2/98/006/008
|
Intervet International Booxmer, Nīderlande
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for suspension
|
| International name (active substance): |
Live attenuated Infectious Bronchitis virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
21-May-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/98/006/008 |
|
10 |
Stikla flakons, 10000 deva |
-
|
|